Uncertainty Market Cap (USD Mil) % Stock Holdings Allergan AGN 2 Wide 208.47 1.13 Medium 61,318 5.3 Appd Mats ..... with a 17.6% weighting for the benchmark index). Allergan AGN "> AGN , which has been the subject of a takeover battle
include Valeant’s offer to acquire Allergan , Merz’s acquisition of BioFarm Medical ..... technologies. The key players covered are Allergan , Q-Med, Mentor, Medicis and Merz ..... technologies. Key players covered include Allergan , Q-Med AB, Mentor Corporation, Medicis
Do you expect to prepare an analyst note anytime soon on Valeant’s prospects following the abortive Allergan deal?
BOSTON (Reuters) - Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc ., his firm's biggest bet of 2014.
(Adds details from Ackman's letter about other investments)
BOSTON, Nov 26 (Reuters) - Hedge fund manager William Ackman told investors in a letter that his firm still owns 26.6 million shares in Allergan Inc . which were valued at $5.6 billion one week after...
The recent spate of merger activity on Wall Street (including last week's $66 billion acquisition of Allergan by Actavis ACT) has raised the profile of a niche segment of the alternative mutual fund universe, merger-arbitrage funds
(Corrects first bullet point to remove incorrect reference to Valeant's prior stake in Allergan )
Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.
Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.